Laxido Paediatric 62.5 ml Powder for oral solution
PDF Leaflet Revision Date: 22 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of chronic constipation in children.
Dosage (summary)
1 sachet daily for ages 2-6; 2 sachets daily for ages 7-11; max 4 sachets/day.
Special Populations
- Impaired cardiovascular function
- Renal insufficiency
Pregnancy & Breastfeeding
Safety in pregnancy not established; negligible exposure during breastfeeding.
Key Drug Interactions
- Reduced absorption of other medicines
- Decreased efficacy with anti-epileptics
Contraindications
- Hypersensitivity to ingredients
- Intestinal perforation or obstruction
- Severe inflammatory bowel conditions
Common side effects
- Abdominal pain
- Diarrhoea
- Nausea
- Vomiting
- Flatulence
Counselling Points
- Maintain adequate fluid intake
- Consult if bowel habits change for over 2 weeks
- Discontinue if rectal bleeding occurs
Serious warnings
- Do not use with abdominal pain, nausea, or vomiting
- Risk of dependence with prolonged use
Important Disclaimer
The Laxido Paediatric 62.5 ml Powder for oral solution professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
